Abbott Laboratories (ABT) News Today → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free abt Stock Alerts $104.87 +0.28 (+0.27%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 9:21 AM | markets.businessinsider.comBuy Recommendation for Abbott Laboratories Backed by Strong Sales Growth and Promising PipelineMay 16 at 8:00 AM | fool.comThese Dividend Stocks Are an Investor's Best FriendMay 16 at 5:52 AM | americanbankingnews.comJr. Robert E. Funck Sells 10,097 Shares of Abbott Laboratories (NYSE:ABT) StockMay 15 at 6:53 PM | marketbeat.comLmcg Investments LLC Boosts Position in Abbott Laboratories (NYSE:ABT)Lmcg Investments LLC lifted its position in Abbott Laboratories (NYSE:ABT - Free Report) by 15.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 149,847 shares of the healthcare prMay 15 at 6:58 AM | insidertrades.comAbbott Laboratories (NYSE:ABT) EVP Jr. Robert E. Funck Sells 10,097 SharesMay 14 at 10:15 PM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Curi Wealth Management LLCCuri Wealth Management LLC reduced its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 12.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 59,283 shares of the healthcare product maker's stock aftMay 14 at 6:43 PM | marketbeat.comInsider Selling: Abbott Laboratories (NYSE:ABT) EVP Sells 10,097 Shares of StockAbbott Laboratories (NYSE:ABT - Get Free Report) EVP Jr. Robert E. Funck sold 10,097 shares of the business's stock in a transaction on Friday, May 10th. The stock was sold at an average price of $104.57, for a total transaction of $1,055,843.29. Following the transaction, the executive vice president now directly owns 211,341 shares of the company's stock, valued at approximately $22,099,928.37. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.May 13 at 6:19 PM | marketbeat.comPrincipal Financial Group Inc. Sells 120,988 Shares of Abbott Laboratories (NYSE:ABT)Principal Financial Group Inc. reduced its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,743,910 shares of the healthcare prMay 12, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA reduced its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 11.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,053,028 shares of the healthcare product mMay 11, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Bought by Dimensional Fund Advisors LPDimensional Fund Advisors LP raised its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 24.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,226,618 shares of the healthcare productMay 11, 2024 | 247wallst.comJP Morgan Has 5 Blue Chip Passive Income Stocks as Top Picks for MayMay 11, 2024 | marketbeat.comPrincipal Securities Inc. Takes $2.93 Million Position in Abbott Laboratories (NYSE:ABT)Principal Securities Inc. bought a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 26,639 shares of the healthcare product maker's stock, valMay 10, 2024 | insidertrades.comLisa D. Earnhardt Sells 22,852 Shares of Abbott Laboratories (NYSE:ABT) StockMay 9, 2024 | marketbeat.comBreed s Hill Capital LLC Invests $895,000 in Abbott Laboratories (NYSE:ABT)Breed s Hill Capital LLC bought a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 8,131 shares of the healthcare product maker's stock,May 9, 2024 | reuters.comDrugmaker Abbott India posts Q4 profit rise on higher salesMay 9, 2024 | americanbankingnews.comAbbott Laboratories (NYSE:ABT) Receives Average Rating of "Moderate Buy" from BrokeragesMay 9, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from AnalystsAbbott Laboratories (NYSE:ABT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the nine brokerages that are currently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendMay 9, 2024 | finance.yahoo.comInsider Sale: Executive Vice President Lisa Earnhardt Sells 22,852 Shares of Abbott ...May 8, 2024 | marketbeat.comSawgrass Asset Management LLC Acquires 33,316 Shares of Abbott Laboratories (NYSE:ABT)Sawgrass Asset Management LLC lifted its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 46.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 104,626 shares of the healthcare proMay 8, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) EVP Lisa D. Earnhardt Sells 22,852 SharesAbbott Laboratories (NYSE:ABT - Get Free Report) EVP Lisa D. Earnhardt sold 22,852 shares of the stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $106.25, for a total transaction of $2,428,025.00. Following the sale, the executive vice president now directly owns 61,462 shares in the company, valued at $6,530,337.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.May 8, 2024 | fool.comGot $1,000? 3 Dividend Stocks to Buy and Hold ForeverMay 8, 2024 | marketbeat.comAbbott Laboratories Q1 Earnings TranscriptMay 7, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Acquired by Apollon Wealth Management LLCApollon Wealth Management LLC lifted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 41.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 64,490 shares of the healthcare product maker's stock afterMay 7, 2024 | markets.businessinsider.comRBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT)May 6, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Stock Position Lifted by Private Advisor Group LLCPrivate Advisor Group LLC lifted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 18.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 167,778 shares of the healthcare product maker's stock after purchasing aMay 5, 2024 | marketbeat.comNational Bank of Canada FI Reduces Position in Abbott Laboratories (NYSE:ABT)National Bank of Canada FI lessened its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 1.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,040,659 shares of the healthcare product maker's stocMay 5, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Bought by Nations Financial Group Inc. IA ADVNations Financial Group Inc. IA ADV raised its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 22.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 39,890 shares of the healthcare product maker's stock after acquiring an additioMay 3, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Purchased by Los Angeles Capital Management LLCLos Angeles Capital Management LLC raised its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 2.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 291,047 shares of the healthcare product maker's stock after acMay 3, 2024 | marketbeat.comBoston Scientific Bucks the Medtech Slow Down and Raises Outlook (ABT)Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.May 3, 2024 | marketbeat.comGraham Capital Wealth Management LLC Buys New Shares in Abbott Laboratories (NYSE:ABT)Graham Capital Wealth Management LLC bought a new stake in Abbott Laboratories (NYSE:ABT - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 12,285 shares of the healthcare product maker's stock, vaMay 2, 2024 | businesswire.comAppriss Retail Names Industry Veteran and Innovator Dean Abbott Chief Data ScientistMay 2, 2024 | msn.com‘Abbott Elementary’: Tyler James Williams on Embracing Gregory’s Jealousy in ‘Double Date’May 1, 2024 | marketbeat.comRaymond James Financial Services Advisors Inc. Acquires 9,365 Shares of Abbott Laboratories (NYSE:ABT)Raymond James Financial Services Advisors Inc. boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 1.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 827,824 shares of the healtMay 1, 2024 | yahoo.com‘Abbott Elementary’ Just Aired Its Cringiest Episode EverMay 1, 2024 | msn.comAbbott gets FDA approval for Esprit BTK stent for PADMay 1, 2024 | investorplace.comStock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices PlungeMay 1, 2024 | yahoo.comGovernor Abbott orders TEA to ignore expanded Title IX ruleApril 30, 2024 | marketbeat.comWaycross Partners LLC Cuts Stake in Abbott Laboratories (NYSE:ABT)Waycross Partners LLC decreased its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 70.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,289 shares of the healthcare product maker's stock after selling 10,200 sharApril 30, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), Iterum Therapeutics (ITRM)April 30, 2024 | investorplace.com7 Defensive Stocks Built to Withstand the Market's Worst StormsApril 29, 2024 | marketbeat.comAmica Mutual Insurance Co. Buys 15,087 Shares of Abbott Laboratories (NYSE:ABT)Amica Mutual Insurance Co. boosted its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 14.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 117,532 shares of the healthcare product maker's stocApril 29, 2024 | markets.businessinsider.comAbbott's Dissolving Stent For People With Chronic Limb-Threatening Ischemia Gets FDA NodApril 29, 2024 | msn.comGreg Abbott Issues Deadly Alligator Warning to MigrantsApril 29, 2024 | prnewswire.comAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the KneeApril 28, 2024 | marketbeat.comRetirement Systems of Alabama Cuts Stock Position in Abbott Laboratories (NYSE:ABT)Retirement Systems of Alabama trimmed its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 7.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,093,549 shares of the healthcare product maker's stock aftApril 28, 2024 | fool.com2 Beaten-Down Dividend Stocks to Buy and Hold ForeverApril 27, 2024 | marketbeat.comRaymond James & Associates Has $358.47 Million Holdings in Abbott Laboratories (NYSE:ABT)Raymond James & Associates boosted its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 3.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,153,909 shares of the healthcare prApril 27, 2024 | marketbeat.comTruist Financial Corp Sells 96,735 Shares of Abbott Laboratories (NYSE:ABT)Truist Financial Corp reduced its position in Abbott Laboratories (NYSE:ABT - Free Report) by 3.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,839,281 shares of the healthcare product maker's stock after selling 96,735 shares during the period.April 26, 2024 | msn.comBella Vista teen drafted to Abbott HeartMates with Damar Hamlin as captainApril 25, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Position Reduced by Bank Julius Baer & Co. Ltd ZurichBank Julius Baer & Co. Ltd Zurich trimmed its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 43.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,141,237 shares of the healthcare product maker's Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… ABT Media Mentions By Week ABT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABT News Sentiment▼1.090.55▲Average Medical News Sentiment ABT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABT Articles This Week▼1618▲ABT Articles Average Week Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PFE News NVS News AZN News SNY News VRTX News REGN News GSK News BMY News ABBV News ZTS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABT) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe 1,000X Crypto PlaybookTrue Market InsidersGold Set to EXPLODE!Gold Safe ExchangeCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMost important medical advance in 100 yearsThe Oxford ClubBill Clinton Backing Biden Replacement???The Freeport SocietyCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
